- Report
- October 2024
- 186 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 135 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 136 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- August 2024
- 233 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- August 2022
- 115 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2022
- 117 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2023
- 381 Pages
Global
€4546EUR$4,995USD£3,897GBP
- Report
- February 2024
- 82 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- November 2021
- 844 Pages
Global
From €4551EUR$5,000USD£3,901GBP

Valproic acid is a drug used to treat epilepsy, bipolar disorder, and migraine headaches. It is a central nervous system (CNS) drug, meaning it acts on the brain and spinal cord to reduce seizures and other symptoms. Valproic acid works by increasing the amount of gamma-aminobutyric acid (GABA) in the brain, which helps to reduce the frequency and severity of seizures. It is also used to treat mania and depression associated with bipolar disorder. Valproic acid is available in both oral and intravenous forms, and is often used in combination with other medications.
Valproic acid is a widely used CNS drug, and is available from many pharmaceutical companies. Some of the companies that produce valproic acid include Pfizer, GlaxoSmithKline, Novartis, and Sanofi. Show Less Read more